---
title: "Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286788482.md"
description: "The US Supreme Court denied petitions from six major pharmaceutical companies, including AstraZeneca and Johnson & Johnson, challenging the legality of the 'Drug Price Negotiation Program' under the Inflation Reduction Act of 2022. The companies did not comment on the decision. The stock price is currently at 183.25, with a change of +1.67 (+0.92%)."
datetime: "2026-05-18T14:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286788482.md)
  - [en](https://longbridge.com/en/news/286788482.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286788482.md)
---

# Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

10:13 AM EDT, 05/18/2026 (MT Newswires) -- The US Supreme Court on Monday denied petitions for writs of certiorari filed by six big pharmaceutical companies seeking to challenge the legality of the so-called 'Drug Price Negotiation Program' under the Inflation Reduction Act of 2022.

AstraZeneca ( AZN ) , Novartis ( NVS ) , Novo Nordisk ( NVO ) , Johnson & Johnson's ( JNJ ) Janssen Pharmaceuticals, Bristol Myers Squibb ( BMY ) and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court.

The companies did not immediately respond to requests for comment from MT Newswires.

Price: 183.25, Change: +1.67, Percent Change: +0.92

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Supreme Court rejects drugmakers’ bid to halt Medicare price talks](https://longbridge.com/en/news/286922283.md)
- [AstraZeneca Gets U.S. Approval for Hypertension Drug](https://longbridge.com/en/news/286724028.md)
- [Companies begin receiving tariff refunds following February Supreme Court decision](https://longbridge.com/en/news/286249203.md)
- [NABU and SAP have expanded the circle of suspects in the case of large-scale corruption in the Supreme Court - reports](https://longbridge.com/en/news/286908753.md)
- [Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer | AZN Stock News](https://longbridge.com/en/news/286621973.md)